Bio Key International Stock Performance
| BKYI Stock | USD 0.92 0.04 4.55% |
On a scale of 0 to 100, BIO Key holds a performance score of 2. The firm shows a Beta (market volatility) of -1.02, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning BIO Key are expected to decrease slowly. On the other hand, during market turmoil, BIO Key is expected to outperform it slightly. Please check BIO Key's treynor ratio and the relationship between the semi variance and price action indicator , to make a quick decision on whether BIO Key's price patterns will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BIO Key International are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, BIO Key demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:18 | Dividend Date 2020-11-20 | Last Split Date 2023-12-21 |
1 | Leading Government Defense Ministry Awards BIO-key 500K In Follow-On Orders for Biometric User Authentication | 09/10/2024 |
2 | Acquisition by Michel Robert J of 1429 shares of BIO Key subject to Rule 16b-3 | 09/18/2024 |
3 | BKYI stock touches 52-week low at 1 amid market challenges - Investing.com India | 09/25/2024 |
4 | BIO-key Accelerates Zero Trust Solutions at Industry-Leading Cybersecurity Conference, ISC Security Congress 2024 | 10/14/2024 |
5 | BIO-key Secures 910,000 Order to Upgrade Long-Time Financial Services Customer to Enhanced Biometric Customer Identification Technology | 10/29/2024 |
6 | Acquisition by Alia Emmanuel of 2587 shares of BIO Key subject to Rule 16b-3 | 11/08/2024 |
7 | ARMISTICE CAPITAL, LLC Acquires New Stake in BIO-key International Inc | 11/15/2024 |
| Begin Period Cash Flow | 2.6 M |
BIO |
BIO Key Relative Risk vs. Return Landscape
If you would invest 136.00 in BIO Key International on August 28, 2024 and sell it today you would lose (44.00) from holding BIO Key International or give up 32.35% of portfolio value over 90 days. BIO Key International is currently generating 0.5056% in daily expected returns and assumes 17.7465% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than BIO, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BIO Key Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIO Key's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIO Key International, and traders can use it to determine the average amount a BIO Key's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0285
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BKYI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 17.75 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average BIO Key is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIO Key by adding it to a well-diversified portfolio.
BIO Key Fundamentals Growth
BIO Stock prices reflect investors' perceptions of the future prospects and financial health of BIO Key, and BIO Key fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIO Stock performance.
| Return On Equity | -4.58 | ||||
| Return On Asset | -0.56 | ||||
| Profit Margin | (0.92) % | ||||
| Operating Margin | (1.45) % | ||||
| Current Valuation | 3.54 M | ||||
| Shares Outstanding | 3.11 M | ||||
| Price To Earning | (2.55) X | ||||
| Price To Book | 21.62 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 7.75 M | ||||
| Gross Profit | 3.44 M | ||||
| EBITDA | (7.85 M) | ||||
| Net Income | (8.52 M) | ||||
| Cash And Equivalents | 4.89 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 365.35 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.50 X | ||||
| Book Value Per Share | (0.58) X | ||||
| Cash Flow From Operations | (3.79 M) | ||||
| Earnings Per Share | (8.66) X | ||||
| Market Capitalization | 3.25 M | ||||
| Total Asset | 4.52 M | ||||
| Retained Earnings | (125.01 M) | ||||
| Working Capital | (591.23 K) | ||||
| Current Asset | 9.88 M | ||||
| Current Liabilities | 1.72 M | ||||
About BIO Key Performance
By evaluating BIO Key's fundamental ratios, stakeholders can gain valuable insights into BIO Key's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BIO Key has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BIO Key has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 25.73 | 24.44 | |
| Return On Tangible Assets | (2.74) | (2.88) | |
| Return On Capital Employed | (6.77) | (6.43) | |
| Return On Assets | (1.89) | (1.98) | |
| Return On Equity | (8.01) | (7.61) |
Things to note about BIO Key International performance evaluation
Checking the ongoing alerts about BIO Key for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIO Key International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BIO Key is way too risky over 90 days horizon | |
| BIO Key has some characteristics of a very speculative penny stock | |
| BIO Key appears to be risky and price may revert if volatility continues | |
| BIO Key has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.75 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 3.44 M. | |
| BIO Key International currently holds about 4.89 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| BIO Key has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: ARMISTICE CAPITAL, LLC Acquires New Stake in BIO-key International Inc |
- Analyzing BIO Key's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIO Key's stock is overvalued or undervalued compared to its peers.
- Examining BIO Key's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BIO Key's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIO Key's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BIO Key's stock. These opinions can provide insight into BIO Key's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |